Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug.
MarketWatch.com - Top Stories, MarketWatch
Thu, 05/07/2020 - 3:45pm
Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug.